BI
NVS icon

Bradyco Inc’s Novartis NVS Stock Holding History

Bradyco Inc’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$915K Hold
5,841
– – 1.05% 23
2026
Q1 		$892K Hold
5,841
– – 0.69% 25
2025
Q4 		$805K Hold
5,841
– – 1% 28
2025
Q3 		$749K Sell
5,841
-850
-13% -$104K 0.85% 29
2025
Q2 		$707K Hold
6,691
– – 0.52% 39
2025
Q1 		$746K Sell
6,691
-500
-7% -$53.2K 0.57% 37
2024
Q4 		$700K Buy
+7,191
New +$767K 0.43% 42

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bradyco Inc's NVS Position: Q2 2026 in Review

Bradyco Inc held its Novartis (NVS) position steady in Q2 2026 at 5,841 shares worth $915K. The position accounts for 1.05% of the portfolio, ranked #23.

Bradyco Inc first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Bradyco Inc held 5,841 shares of Novartis worth $915K as of Q2 2026.
  • Bradyco Inc left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 1.05% of Bradyco Inc's portfolio in Q2 2026, its #23 holding.
  • Bradyco Inc first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bradyco Inc's 13F filing for Q2 2026, filed 11 Aug 2026.